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Abstract
Introduction: Integrated Care Pathways (ICPs) are a method for the mutual decision-making and organization of care
for a well-defined group of patients during a well-defined period. The aim of a care pathway is to enhance the quality of
care by improving patient outcomes, promoting patient safety, increasing patient satisfaction, and optimizing the use of
resources. To describe this concept, different names are used, e.g. care pathways and integrated care pathways. Modern
information technologies (IT) can support ICPs by enabling patient empowerment, better management, and the moni-
toring of care provided by multidisciplinary teams. This study analyses ICPs across Europe, identifying commonalities and
success factors to establish good practices for IT-supported ICPs in diabetes care.
Methods: A mixed-method approach was applied, combining desk research on 24 projects from the European
Innovation Partnership on Active and Healthy Ageing (EIP on AHA) with follow-up interviews of project participants,
and a non-systematic literature review. We applied a Delphi technique to select process and outcome indicators, derived
from different literature sources which were compiled and applied for the identification of successful good practices.
Results: Desk research identified sixteen projects featuring IT-supported ICPs, mostly derived from the EIP on AHA, as
good practices based on our criteria. Follow-up interviews were then conducted with representatives from 9 of the 16
projects to gather information not publicly available and understand how these projects were meeting the identified
criteria. In parallel, the non-systematic literature review of 434 PubMed search results revealed a total of eight relevant
projects. On the basis of the selected EIP on AHA project data and non-systematic literature review, no commonalities
with regard to defined process or outcome indicators could be identified through our approach. Conversely, the
research produced a heterogeneous picture in all aspects of the projects’ indicators. Data from desk research and
follow-up interviews partly lacked information on outcome and performance, which limited the comparison between
practices.
Conclusion: Applying a comprehensive set of indicators in a multi-method approach to assess the projects included in
this research study did not reveal any obvious commonalities which might serve as a blueprint for future IT-supported
ICP projects. Instead, an unexpected high degree of heterogeneity was observed, that may reflect diverse local imple-
mentation requirements e.g. specificities of the local healthcare system, local regulations, or preexisting structures used
for the project setup. Improving the definition of and reporting on project outcomes could help advance research on and
implementation of effective integrated care solutions for chronic disease management across Europe.
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Introduction
Diabetes represents a growing challenge for health care
systems everywhere. Its prevalence has been growing
continuously over the last decades,1 with the ﬁnancial
and human burden on healthcare systems increasing as
a result. In addition, diabetes is linked to a high risk of
comorbidities including depression and cardiovascular
diseases, resulting in complications such as retinopathy,
nephropathy, neuropathy, stroke, dementia, or lower
extremity amputations.2 The need to treat such long-
term chronic conditions, which often require multiple
complex interventions, only adds to the pressure on
health systems already dealing with the impact of an
aging population.3
Finding sustainable solutions to curb the morbidity,
mortality, and disability associated with major chronic
diseases has become an urgent priority for health prac-
titioners and policymakers.4 Moreover, there is a need
for a paradigm shift in how health services are funded,
managed, and delivered.3 In Europe, such services are
being restructured to meet changing care needs, via the
development and implementation of new, more innova-
tive approaches.5
Of these, integrated care (IC) has emerged as one of
the most promising strategies, with many countries
prioritizing it as a means to support the improvement
of health outcomes for people at risk of or living with
chronic illnesses.4,6 More speciﬁcally, integrated care
pathways (ICPs) are personalized, structured multidis-
ciplinary care plans, which outline essential steps for
the care of patients with speciﬁc clinical and/or social
problems.7 They also support the transposition of
national guidelines into local protocols and daily care
practice. ICPs diﬀer from practice guidelines in that
they are used by a multidisciplinary team, and focus
on improving the quality and coordination of care.8
From a patient’s perspective, integrated care aims to
meet both their health and social needs, taking these as
the starting point for redesigning their care. Better
coordination and continuity of care not only make
for an easier patient journey through treatment; they
also contribute to improved outcomes.9,10 To this end,
integrated care can drive greater eﬃciency and value
within health care delivery systems, beneﬁting patients,
healthcare providers, and care systems alike.9,10
Multidisciplinary care delivery is to a large extent an
information-driven process. Technology for collecting
and exchanging information is considered essential to
make integrated care work for all stakeholders
involved.11 Current developments in information tech-
nologies (ITs) can be the ultimate facilitators for inte-
grated care models.11 Modern diabetes management is
an example of this, making use of internet-enabled
devices such as glucose meters, insulin pumps, activity
trackers, and calorie counters (through wearables and
smartphones), or allowing patient–carer interaction.11
Furthermore, the data generated by such devices and
systems can provide insights into how to further
improve operations and decision-making within health-
care services.12 ICPs also enable the systematic collec-
tion and analysis of relevant data for the purposes of
audit, or to promote changes in practice.7 However, it is
worth noting that important and necessary functional-
ities for health technology remain limited, as do suﬃ-
cient interoperability and an eﬀective roadmap for the
implementation and deployment of such
technologies.11,13
Integrated care hinges on a tailored combination of
the right structures, processes, and methodologies to
address a patient’s needs, alongside speciﬁc institutional
and community circumstances.10 Thus, local settings are
the most appropriate context for the tailored develop-
ment, implementation, and deployment of ICPs.14 Since
there is no ‘‘one size ﬁts all’’ or silver-bullet solution for
ICPs,1,10 it’s important to study the features of success-
ful IT-supported ICPs for diabetes patients.
The aim of this study was therefore to identify com-
monalities in good practices of IT-supported ICPs for
patients with diabetes mellitus, and subsequently better
understand when these ICPs are successful, and for
what kind of patients.
Definitions applied in the research
The European Commission (EC) deﬁnes ‘‘good or best
practices’’ in the area of active and healthy aging as
real-life examples of successful applied innovations.5
Meanwhile, the European Innovation Partnership on
Active and Healthy Ageing (EIP on AHA) initiative,
which is supported by the EC, identiﬁes a ‘‘good prac-
tice’’ by its feasibility and potential for replicability
under various conditions,5 considering ‘‘good’’ and
‘‘best’’ practices to be interchangeable.
To date, there is no standardized deﬁnition of inte-
grated care pathway that has been developed for the
management of chronic diseases or, more speciﬁcally,
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on diabetes. Several organizational models have been
created to implement integrated care pathway
approaches that are known under the name of care
management programmes, disease management, popula-
tion management, and chronic care models, to mention
but a few.15
According to Perleth et al.,16 an activity, discipline,
or method available for identifying, implementing, and
monitoring available healthcare evidence is dubbed a
‘‘best practice’’. These can be further identiﬁed accord-
ing to three criteria: input, implementation or dissem-
ination, and outcome. To measure the improvement of
a health care system’s performance, Perleth et al.16 sug-
gest further criteria related to safety, eﬃcacy, eﬀective-
ness, cost-eﬀectiveness, the appropriateness of health
care interventions, the quality of healthcare, and
public perception. In addition, the authors recommend
taking a collective approach to information-gathering
and management since no single one of these
approaches forms an entirely successful and all-embra-
cing strategy for ascertaining what constitutes best
practice.
Several examples of IC ‘‘good practice’’ models are
described in the scientiﬁc literature.5,6,16–26 Integrated
care is associated with a number of positive outcomes,
including an improvement in system performance, clin-
ical results, service delivery, and patient satisfaction.17
However, due to the complex, disruptive and context-
speciﬁc nature of health care service transformation, it
is often diﬃcult to directly measure its eﬀects in terms
of eﬃcacy and eﬃciency.5 Failure to recognize the
widely varying deﬁnitions and components of ICPs
can lead to inappropriate conclusions being drawn in
regards to the eﬀectiveness of such programmes.19
According to Busetto et al.,6 the diﬀerences in def-
initions and operationalization of IC interventions, as
well as the diﬀerent classiﬁcations of interventions and/
or of their components, can make it nearly impossible
to compare reviews investigating the relative eﬀective-
ness of IC, or to draw overarching conclusions. With
this in mind, the chronic care model (CCM) has been
proposed in order to narrow down an operational def-
inition of IC that allows for the systematic, reliable
identiﬁcation, and categorization of diﬀerent kinds of
IC interventions.6,20 This model suggests that improv-
ing integrated chronic care requires changes in six
areas: community, the health system, self-management
support, delivery system design, decision support, and
clinical information systems.20 Of these six, the latter
four are considered to be the priority when it comes to
improving matters.6
A systematic review of integrated healthcare models
delivered at the primary–secondary care stage identiﬁed
the characteristics of models that lead to favorable clin-
ical outcomes.18 The six common features are
interdisciplinary teamwork, communication/informa-
tion exchange, shared care guidelines or pathways,
training and education, patient access and acceptance,
and a viable funding model.18
These overlap with the World Health Organization’s
concept of ‘‘building blocks’’ for care; an expansion of
the earlier mentioned CCM21 entitled the Innovative
Care for Chronic Conditions (ICCC) Framework.
This is based on a set of guiding principles fundamental
to the micro- meso-, and macro-level organization of
the healthcare system.22
Based on the above, we developed a set of process
and outcome indicators by using Delphi-technique
described in the methods section, which is listed in
Table 1, to select ‘‘good practices’’ and to identify the
criteria for successful IT-supported integrated care
pathways.5,6,16–26
Methods
A methodological triangulation strategy was used to
identify, describe and compare IT-supported ICPs for
diabetes, which were recognized as ‘‘good practices’’ in
their original documentation. In doing so, three related
methods were applied: desk research, a non-systematic,
narrative literature review, and a survey, which was
followed by in-depth interviews with project partici-
pants to gather additional data and expand the insights
obtained via the other data collection methods.
The desk research took as its primary source a pub-
lication of the EIP on AHA,26 outlining a new
approach to research and innovation bringing together
all relevant actors at all levels. The EIP on AHA’s goal
is to share knowledge on good practices for active and
healthy aging, including integrated care, and to deploy
these across a network of European regions across
Europe known as reference sites.
In November 2015, the EIP on AHA’s Action
Group on integrated care for chronic diseases presented
a report compiling such 86 good practices.26 Of these,
we selected several projects fulﬁlling the following
inclusion criteria: they related to people with chronic
diseases, in particular diabetes, with comorbidities in
European countries, and they incorporated any kind
of IT support where digital information between
people and/or devices was exchanged.
Given the European Commission’s current work in
the area of chronic disease management, we comple-
mented the research with an examination of other
good practices identiﬁed within the Chrodis Joint
Action.27 JA-CHRODIS is a European collaboration
that brings together over 70 associated and collaborat-
ing partners from national and regional departments of
health and research institutions in 25 European coun-
tries. These partners work together to identify, validate,
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exchange, and disseminate good practice on chronic
diseases across EU Member States.
To capture other good practices of IT-supported
ICPs beyond those featured within the EIP on AHA,5
a non-systematic, narrative review was performed using
PubMed, screening all articles published between 1984
and May 2016 using the terms ‘‘diabetes’’, ‘‘IT’’, and
‘‘integrated care’’ in any ﬁeld (research date: 30 May
2016). Non-European projects, studies focusing on
technical developments, and studies focused on diseases
other than diabetes mellitus were excluded.
To describe and compare selected ICPs, the research
team used the process and outcome indicators listed in
Table 1. We applied a Delphi technique as a structured
process of ‘‘rounds’’ to collect information among our
investigation group. Rounds were held until group con-
sensus has been reached. An initial face-to-face meeting
aligned experts with the purpose of the consensus build-
ing process; this was followed by two anonymous
survey rounds using an internet platform on the diﬀer-
ent dimensions on process and outcome indicators to
characterize ICP.
The following steps were completed in this modiﬁed
Delphi process: (1) the investigators agreed upon a set
of principles to guide the development of the indicators’
list; (2) a small working group of investigators scanned
the available literature to identify key resources on ICP;
(3) a draft document was created based on these reviews
and inputs; (4) an expert stakeholder meeting was held
to discuss and conﬁrm the issues; (5) two rounds of an
on-line survey were completed to revise and reach con-
sensus on the pathway; (6) all the investigators partici-
pated in focus groups to validate the list, and (7) a ﬁnal
meeting conﬁrmed the ﬁnal version of the indicators.
As far as possible, interviews were conducted with
representatives of the projects selected from the EIP on
AHA catalogue26,27 to gather additional data.
Interviewees were invited to take part in a 30-min
phone interview and to provide additional information
on the metrics and data used to assess the impact of the
practice. The survey included the process and outcome
indicators mentioned in Table 1. A complete question-
naire can be found in the Appendix of this article.
Results
Desk research
A total of 16 IT-supported ICPs recognized as ‘‘good
practice’’ were identiﬁed as meeting our inclusion cri-
teria (Table 2, see Appendix).26,28–30
The selected projects came from several European
countries and from diﬀerent regions, including Spain,6
Italy,4 and one each from Denmark, France, Germany,
the Netherlands, the United Kingdom, and Ireland.
The ICPs diﬀer in their stated goals, the composition
of the multidisciplinary teams, patient characteristics,
number of integrated patients, and local environment
(clinic and ambulant settings). According to informa-
tion available in the EIP AHA catalogue and in the
literature, the 16 projects featured outcome indicators
such as hospitalization,11 cost savings,9 patient satisfac-
tion,4 and the satisfaction of health care professionals
(HCP).2
Literature review
The non-systematic literature review yielded 434
results. After exclusion of reviews and other compara-
tive analysis (N¼ 61), non-European projects (N¼ 56),
articles on technical development or other common
care subjects (N¼ 128), and articles focused on diseases
other than diabetes mellitus (N¼ 175), 13 articles
remained. Of these, ﬁve articles included redundant
information which was covered in other references
and were therefore removed from this analysis, result-
ing in a ﬁnal total of eight original projects (Figure
1).31–40
The majority of the projects were located in Spain
and Norway (see Table 2, Appendix). Similar to the
desk research, the projects identiﬁed in the non-sys-
tematic review research diﬀered with respect to their
objectives, patient and staﬀ characteristics, organiza-
tional structure, and local environment. Projects from
the nonsystematic review integrated a measurement of
diﬀerent outcome indicators such as hospitalization,
cost-savings, and physiological parameters. Four pro-
jects implemented a comparator group to control the
eﬀectiveness of the projects.31,35,36,38
Survey results
Participants from 9 out of the 16 selected projects
(56%) agreed to take part in the follow-up interviews.
These were conducted with representatives of the pro-
jects (Table 3, Appendix).
All projects investigated received public funding and
relied on multidisciplinary teams for implementation.
Seven projects involved public authorities at various
stages, seven used eHealth tools, and provided patient
education and capacity-building.41 The few practices
relying on m-Health reported using apps or Skype to
connect patients and services, and vice-versa. Seven
projects reported involving patients at diﬀerent stages
of the practice. ‘‘eHealth’’ generally refers to the use of
information technology, including the Internet, digital
gaming, virtual reality, and robotics, in the promotion,
prevention, treatment, and maintenance of health.
‘‘mHealth’’ refers to mobile and wireless applications,
including text messaging, apps, wearable devices,
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remote sensing, and the use of social media such as
Facebook and Twitter, in the delivery of health-related
services.42,43
Usually patients were involved to solicit feedback on
the practice worked and how it could be improved.
Further patient empowerment was recognized as an
area for improvement—respondents believed that
there were not enough existing tools and activities
available to empower patients.
The respondent identiﬁed an improvement in commu-
nication between patients and HCPs, as well as an increase
in patient satisfaction (evaluated by surveys, semi-struc-
tured interviews or workshops within the projects), as
advantages of IT-supported ICPs in diabetes. However,
it was found that patient access to health records remains
unequal and that social and psychological support is not
suﬃciently embedded in the practices. Most practices did
not measure outcomes such as impact on physiologic par-
ameters, hospitalization, or cost-savings.
Discussion
Our research reviewed 24 examples of IT-supported
ICPs in diabetes and chronic diseases which have been
applied in diﬀerent regional settings and were identiﬁed
as ‘‘good practices’’. A comparative analysis neverthe-
less demonstrated a surprising level of heterogeneity.
While their implementation is—as a whole—likely to
have positive impacts on process, outcome and eco-
nomic dimensions of care,44 the ICPs showed diﬀer-
ences in objectives, the composition of the
multidisciplinary teams, patient characteristics, organ-
ization, and local environment. In addition, the assess-
ment of potential success factors did not reveal
commonalities which could serve as a starting point
to develop ICPs in diabetes throughout Europe.
However, the survey results did provide insights into
the possible motivations for local healthcare systems to
implement integrated care pathways for diabetes.
Representatives surveyed reported improved communi-
cation between HCPs and patients, a greater satisfaction
for both groups, and/or increased patient empowerment.
However, these process indicators were not systematic-
ally analysed, and the understanding of what was meant
by ‘‘improved communication’’ varied according to
respondents; some took it to mean an increase in the
level of communication, while other understood it as
an improved perception of the doctor–patient relation-
ship, and/or better adherence to treatment.
When focusing on ITs we found that within the
majority of the ICPs, ITs were used to facilitate
remote management between patients and HCPs. The
use of ITs, in particular tele-health, for the support of
integrated care for long-term chronic conditions has
been described as useful and eﬀective.36 However, the
existing status of IT-supported ICPs suggests that they
are only currently being used to a fraction of their full
potential.
Our analysis shows that, while good practice projects
should have predeﬁned objectives and outcome indica-
tors, only a few of the selected projects actually mea-
sured hard outcomes, such as impact on physiologic
parameters, hospitalizations, or cost-savings. The
number of ICP projects, which applied a comparator
group to assess the eﬀectiveness of ICPs31,35,36,38 was
even lower. It is therefore diﬃcult to derive conclusions
about the comparative eﬀectiveness of ICPs.
We applied the Delphi technique as described by
Kro¨ger et al.45 to develop process and outcomes indi-
cators, since such an approach has been applied on
chronic illness,46 performance indicators,47 and indica-
tors for cardiovascular disease.48
Excluded
Reviews / comparave analyses  N = 61
Non-European projects   N = 56
Focus on technical developments  
or common (e-health) care subjects  N = 128 
Focus on other diseases /Not
speciﬁc for diabetes mellitus  N = 176  
PubMed-Research
N = 434
Projects screened by 
abstract and/or whole 
arcle
N = 13
Excluded
Duplicates (arcles on the same projects) N = 5
Included projects
N = 8
Figure 1. Flow chart of research results from the PubMed research (search criteria: ‘‘diabetes’’, ‘‘IT’’, and ‘‘integrated care’’).
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We are aware that a certain degree of uncertainty
exists concerning the parameters of the Delphi tech-
nique such as the deﬁnition of group consensus,
Delphi technique variants, expert selection, number of
rounds, and reporting of the method and results.49 In
addition, the set of indicators identiﬁed throughout the
process might well be incomplete, thus preventing the
discovery of potential commonalities. Taken together,
these limitations of our methodological approach may
have lead to gaps in the set of indicators and the sub-
sequent identiﬁcation of commonalities.
By using a methodological triangulation strategy,
not only could we include projects which have been
extensively evaluated, but we were also able to include
ongoing projects which have not yet been published in a
scientiﬁc journal or other formal report. In addition,
the projects from the EIP on AHA were followed-up
with a structured survey to garner further insights.
However, since only 9 out of 16 project representatives
took part in an interview, it was diﬃcult to draw a
complete picture of all identiﬁed projects. This illu-
strated the diﬃculty of collecting data around ICP pro-
jects even when making use of multiple methods.
The current use of the labels ‘‘good practice’’ or
‘‘best practice’’ should concern policymakers and
healthcare providers as much as researchers. It remains
unclear what the labels ‘‘good practice’’ and ‘‘best prac-
tice’’ mean exactly, since no homogeneous deﬁnition
has emerged from the collected data, making it diﬃcult
to distinguish and evaluate the two. To monitor the
ongoing development and success of a project, it is
essential to identify, document, and systematically
evaluate goals and outcomes, rather than relying on
arbitrary labels of ‘‘good practice’’ or ‘‘best practice’’.
When comparing the dataset obtained through desk
research with the literature review results, we found that
no articles on the EIP on AHA projects had been pub-
lished in the timeframe covered in the PubMed research
(1984 until May 2016). The EIP on AHA report on good
practices was published in November 2013, and most of
the projects had been running for longer than one year at
that time. The follow-up interviews could only partly ﬁll
this gap; interviewees were available for only 9 of the 16
projects and the information obtained did not always
clarify why the respective projects had been labelled as
‘‘good practice’’.
The lack of published data raises the question of
how to draw substantial conclusions about the success
of the projects, as well as limiting the ability to design a
blueprint for future projects based on these practices, as
there are not enough learnings on how to avoid mis-
steps made in the existing good practices. Hence, the
lack of published data risks hampering further research.
The conclusion must be drawn that any support or
funding for projects in the ﬁeld of ICP should require
robust documentation, and the expectation that as far
as possible, the outcomes of these projects be published
according to acknowledged standards. This may not be
feasible for all projects, such as those with limited
resources and the need to put patient care above
research eﬀorts, but raising these issues before embark-
ing on a project would be a ﬁrst step towards greater
transparency and consistency.
Currently available data display too much hetero-
geneity in all aspects of the ICP projects identiﬁed as
good practices. The reasons behind this are diverse, but
likely include the variance between diﬀerent national
European healthcare systems. In many countries, the
organization of healthcare delivery is largely a regional
responsibility, but funding mechanisms and healthcare
provider responsibilities may also be organized diﬀer-
ently. It is also arguable that variance may be linked to
a lack of standardized deﬁnition of integrated care
pathways. Eﬀorts to seek consensus on a deﬁnition
of integrated care pathway for chronic diseases may
help address some of the weaknesses identiﬁed in this
paper.
Conclusions
European health systems are still ‘‘disease oriented’’
and managed around single medical specialties, thus
fragmenting and poorly coordinating care. IT-sup-
ported integrated care pathways in diabetes show a
great variability in their practical implementation. As
a multi-dimensional tool, ICPs diﬀer in their objectives,
design, process, and outcome indicators. This makes
them adaptable to local needs and diﬀerent health
care systems, but complicates the identiﬁcation of gen-
eral criteria for ICP in the ﬁeld of diabetes.
That being said, and on the basis of our ﬁndings, we
recommend that an ICP on diabetes ideally should
include:
1. A multidisciplinary and multistakeholder project
group involving representatives of all HCPs, public
stakeholders and patients for the deﬁnition of the
Diabetes IC Protocol and for the monitoring of
indicators;
2. A detailed protocol which translates and standard-
izes the best evidence into the local context, and
deﬁnes the roles, tasks, responsibilities, indicators,
and targets (to be updated regularly);
3. A disease registry and computerized system for pro-
cess monitoring to assess the epidemiology dynam-
ics, the application of ICP protocol, management
costs, and the achievement of objectives;
4. An evaluation framework collecting quantitative
and qualitative information including patient-
reported outcomes;
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5. A continuous education programme for all HCPs,
public stakeholders, and patients to ensure the
upscaling of the IC model among European coun-
tries, regardless of the healthcare systems govern-
ance, and the collection of organizational,
ﬁnancial, and technological needs for the improve-
ment of the care model, including primary, and sec-
ondary care.
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Appendix
Table 1. Process and outcome indicators used in the analysis of selected projects from the desk research and the non-systematic
literature review (collected criteria from studies shown in Table 2, see appendix).
Type Item Questions/Implications
Process indicators Involvement of public
authorities
Are local authorities involved in the coordination and/or organ-
ization of the ICP? How? Was the implementation of the care
ICP financially supported by a public authority? How?
Involvement of private
stakeholders
Are other nonstate organizations (professional organizations,
medical societies, patients’ representatives, insurers, etc.)
involved in the implementation or evaluation of the ICP? How?
Multidisciplinary
teamwork
Are HCPs from both primary and secondary care from different
fields actively and systematically engaged in the implementation
of care pathways and/or care guidelines in the ICP? How?
Patient stratification How many patients are involved in your pathway? Are risk
groups identified and selected based on specificities related to
the management of their disease (e.g. age, other complications,
BMI, etc.)? What are the parameters for inclusion of patients in
the selection?
Patient empowerment Has responsibility for management of the disease shifted more
actively towards patients? How? Does the practice offer
social and psychological support to patients and
families? Does the practice include educational and capacity-
building activities? Does the practice provide for a better
access to health records?
Patient involvement Are patients directly involved in the design, implementation and
evaluation of the ICP? How?
Range of use of e-health
tools/ Range of use of
m-health tools
Are there any e-health tools used within the delivery of health
care allowing the transmission of health data from patients to
health care professionals by use of mobile devices? Are there
any m-health tools used within the delivery of health care
allowing the transmission of health data from patients to health
care professionals by use of mobile devices?
Outcome indicators Hospitalization Did the implementation of the pathway help to decrease hospi-
talization rates in the group of patients involved?
Cost saving Were there any cost savings achieved by the practice? (Cost sav-
ings related to treatment of acute episodes, use of health care
facilities, sick leave, and absenteeism)
Satisfaction of patients Was patient satisfaction with the pathway measured (question-
naire, survey, etc.)? What is the level of reported satisfaction?
Satisfaction of HCPs Was HCP satisfaction with the pathway measured (questionnaire,
survey, etc.)? What is the level of reported satisfaction?
Scalability Has the pathway been implemented/ transferred to another
region and/ or country? What impact did it have?
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